Increases the research and development tax credit exchange rate to 100% for biotechnology companies.
The bill amends section 12-217ee of the general statutes to increase the research and development tax credit exchange rate to 100% for biotechnology companies. This change aims to provide greater financial incentives for biotechnology companies to invest in research and development activities. The increased tax credit rate is intended to support innovation and growth within the biotechnology sector.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.